Clinical Trials Directory

Trials / Completed

CompletedNCT03370848

Effects of Psyllium on Niacin Tolerability

A Prospective Randomized, Open-Label, Crossover Study on the Effects of Psyllium on Niacin Tolerability

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
26 (actual)
Sponsor
VA Greater Los Angeles Healthcare System · Federal
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether psyllium is effective in reducing flushing due to niacin and also to measure the effect of niacin on cholesterol levels.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPsylliumAspirin 325 mg tablet and two 1.7gm psyllium wafers (3.4gm total) 30 minutes prior to niacin ER
DRUGAspirinAspirin 325 mg tablet 30 minutes prior to niacin ER

Timeline

Start date
2009-03-01
Primary completion
2011-07-01
Completion
2011-07-01
First posted
2017-12-12
Last updated
2017-12-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03370848. Inclusion in this directory is not an endorsement.